Journal of Rehabilitation Research & Development (JRRD)

Quick Links

  • Health Programs
  • Protect your health
  • Learn more: A-Z Health
Veterans Crisis Line Badge
At a Glance

Proposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA)

Dawn Konrad-Martin, PhD, et al.

An effective treatment for some cancer is cisplatin chemotherapy; however, a potential side effect of cisplatin is hearing loss. This article describes a new, comprehensive Department of Veterans Affairs program for ototoxicity monitoring done while the Veteran receives treatment, with the goal of preventing or minimizing hearing loss when possible. When appropriate, treatment changes that might minimize hearing damage include dose reduction, omission, or substitution to a less toxic chemotherapy drug. The approach is patient centered, with audiology and oncology services working together to improve communication and coordination of care between them for the benefit of Veterans and their families.

Volume 51 Number 1, 2014
   Pages 81 — 100

View HTML ¦ View PDF ¦ Contents Vol. 51, No.1
This article and any supplementary material should be cited as follows:
Konrad-Martin D, Reavis KM, McMillan G, Helt WJ, Dille M. Proposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA). J Rehabil Res Dev. 2014;51(1):81–100.

Go to TOP

Last Reviewed or Updated  Wednesday, April 9, 2014 9:57 AM

Valid HTML 4.01 Transitional